FDA Import Refusal SCS-4758501-5/11/2 — Strides Pharma Science Limited
The FDA refused shipment SCS-4758501-5/11/2 from Strides Pharma Science Limited (India) on June 7, 2021. The refused product falls under Drugs and Biologics — TACROLIMUS (IMMUNOSUPPRESSIVE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 7, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64TCE08 TACROLIMUS (IMMUNOSUPPRESSIVE)
- Charges
- 75